4.6 Article

Can the fNIRS-derived neural biomarker better discriminate mild cognitive impairment than a neuropsychological screening test?

Journal

FRONTIERS IN AGING NEUROSCIENCE
Volume 15, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2023.1137283

Keywords

mild cognitive impairment; functional near-infrared spectroscopy; hemodynamic response; biomarker; discrimination

Ask authors/readers for more resources

This study evaluated the application of a biomarker (changes in oxy-hemoglobin concentration) measured by functional near-infrared spectroscopy (fNIRS) in screening mild cognitive impairment (MCI). The findings revealed significant reductions in oxy-hemoglobin concentration in the prefrontal cortex (PFC) in the MCI group. The average oxy-hemoglobin concentration (mHbO) in the left PFC showed higher discriminant power for MCI than the Korean version of montreal cognitive assessment (MoCA-K).
IntroductionEarly detection of mild cognitive impairment (MCI), a pre-clinical stage of Alzheimer's disease (AD), has been highlighted as it could be beneficial to prevent progression to AD. Although prior studies on MCI screening have been conducted, the optimized detection way remain unclear yet. Recently, the potential of biomarker for MCI has gained a lot of attention due to a relatively low discriminant power of clinical screening tools. MethodsThis study evaluated biomarkers for screening MCI by performing a verbal digit span task (VDST) using functional near-infrared spectroscopy (fNIRS) to measure signals from the prefrontal cortex (PFC) from a group of 84 healthy controls and 52 subjects with MCI. The concentration changes of oxy-hemoglobin (HbO) were explored during the task in subject groups. ResultsFindings revealed that significant reductions in HbO concentration were observed in the PFC in the MCI group. Specially, the mean of HbO (mHbO) in the left PFC showed the highest discriminant power for MCI, which was higher than that of the Korean version of montreal cognitive assessment (MoCA-K) widely used as a screening tool for MCI. Furthermore, the mHbO in the PFC during the VDST was identified to be significantly correlated to the MoCA-K scores. DiscussionThese findings shed new light on the feasibility and superiority of fNIRS-derived neural biomarker for screening MCI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available